MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$31,146K
Free Cash flow
$87,918K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accrued payroll expenses
Net income (loss)
Stock-based compensation
Others
Negative Cash Flow Breakdown
Repurchases of common stock
Operating lease liabilities
Purchases of property and equipm...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
23,612
14,243
11,668
1,077
Depreciation and amortization
14,249
13,318
13,434
13,557
Non-cash operating lease costs
10,946
10,717
10,642
10,596
Stock-based compensation
19,748
15,201
16,704
18,297
Deferred income taxes
-
-
2,422
-
Loss on debt extinguishment
-
-
0
-
Amortization of discount and debt issue costs
253
251
257
256
Gain on remeasurement of contingent consideration
-
-
0
0
Other, net
-1,154
-129
-590
-687
Patient accounts receivable, net
-12,551
26,953
-25,363
-8,411
Prepaid expenses and other current assets
2,969
-33,779
36,275
-4,769
Accounts payable
4,963
-1,017
-4,431
3,145
Accrued payroll expenses
31,792
-26,362
29,555
-15,414
Operating lease liabilities
-12,581
-9,955
-12,300
-12,331
Other accrued expenses
-3,806
9,758
-69
-5,763
Net cash provided by operating activities
99,912
33,109
57,560
27,287
Purchases of property and equipment
11,994
10,767
10,911
10,291
Acquisitions of businesses, net of cash acquired
5,894
3,144
0
-
Net cash used in investing activities
-17,888
-13,911
-10,911
-10,291
Proceeds from long-term debt, net of discount
-
-
0
-
Payments of debt issue costs
-
-
0
-
Payments of long-term debt
7,250
0
1,812
1,813
Payments of contingent consideration
-
-
0
0
Taxes related to net share settlement of equity awards
478
23,936
98
209
Proceeds from the exercise of stock options
5,368
-
-
-
Repurchases of common stock
48,518
49,107
-
-
Net cash used in financing activities
-50,878
-73,043
-1,910
-2,022
Net (decrease) increase in cash and cash equivalents
31,146
-53,845
44,739
14,974
Cash and cash equivalents - beginning of period
194,797
248,642
134,336
134,336
Cash and cash equivalents end of period
225,943
194,797
248,642
203,903
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Accrued payroll
expenses
$31,792K
(8.63%↑ Y/Y)
Net income (loss)
$23,612K
(722.84%↑ Y/Y)
Stock-based compensation
$19,748K
(-6.48%↓ Y/Y)
Depreciation and
amortization
$14,249K
(1.73%↑ Y/Y)
Patient accounts
receivable, net
-$12,551K
(-15.29%↓ Y/Y)
Non-cash operating lease
costs
$10,946K
(4.87%↑ Y/Y)
Accounts payable
$4,963K
(2581.50%↑ Y/Y)
Other, net
-$1,154K
(-191.41%↓ Y/Y)
Amortization of discount and
debt issue costs
$253K
(-0.78%↓ Y/Y)
Net cash provided by
operating activities
$99,912K
(55.15%↑ Y/Y)
Canceled cashflow
$19,356K
Net (decrease)
increase in cash and cash...
$31,146K
(-42.95%↓ Y/Y)
Canceled cashflow
$68,766K
Operating lease
liabilities
-$12,581K
(-8.42%↓ Y/Y)
Other accrued
expenses
-$3,806K
(-188.66%↓ Y/Y)
Prepaid expenses and
other current assets
$2,969K
(-72.16%↓ Y/Y)
Proceeds from the
exercise of stock options
$5,368K
Net cash used in
financing activities
-$50,878K
(-2384.28%↓ Y/Y)
Net cash used in
investing activities
-$17,888K
(-130.66%↓ Y/Y)
Canceled cashflow
$5,368K
Repurchases of common stock
$48,518K
Payments of long-term
debt
$7,250K
(300.11%↑ Y/Y)
Purchases of property and
equipment
$11,994K
(54.66%↑ Y/Y)
Acquisitions of businesses,
net of cash acquired
$5,894K
Taxes related to net
share settlement of...
$478K
(102.54%↑ Y/Y)
Buy us a coffee
lifestance-svg
LifeStance Health Group, Inc. (LFST)
lifestance-svg
LifeStance Health Group, Inc. (LFST)